Position in SCLX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$684,610
-$515,048 QoQ
Shares Held
102,796
+4.5% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BlackRock, Inc. holds $235,198,236,104 across 20 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
66,380,842 | $61,055,107,035 | |
| 2 | JNJ |
Johnson & Johnson
|
213,385,546 | $52,159,962,852 | |
| 3 | ABBV |
AbbVie Inc.
|
150,698,125 | $32,775,335,197 | |
| 4 | MRK |
Merck & Co., Inc.
|
225,830,330 | $27,165,130,383 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
119,010,973 | $16,586,559,291 | |
| 6 | AMGN |
Amgen Inc
|
47,100,472 | $16,572,301,062 | |
| 7 | PFE |
Pfizer Inc
|
498,257,550 | $13,991,071,992 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
171,682,888 | $10,412,567,149 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $684,610 | 102,796 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,199,658 | 98,333 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,936,147 | 98,382 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $779,434 | 132,332 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||